Policy & Regulation


Business


  • Non-US Approvals - Clone

    Devices authorized for marketing outside the US. Data derived from Citeline’s Meddevicetracker. Updated weekly.

  • Nancy Tests Arc AI Editor

     
    • By 

    Curve Biosciences has developed a "Whole-Body Intelligence" platform using cfDNA from blood to monitor chronic diseases, starting with the liver. Focused on liver cirrhosis and MASH, the company aims to aid in treatment decisions and plans to expand into monitoring other organs.

  • Asking For More: Supplement MPL Authority For FDA, Agency Results For Congress, Industry

    Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.

Innovation & IP